Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence study of Trimetazidine dihydrochloride PR capsules under fed conditions in healthy Thai volunteers
TCTR20230320011Phase 1Completed
- Sponsor
- Unison Laboratories
- Start
- May 2023
- Countries
- 1
01
Overview
Phase 1, open-label trial (2 arms), sponsored by Unison Laboratories. Primary endpoints: Cmax, AUC0-t and 1 more. Started May 2023; status: completed.
Beyond the preview
Go deeper on TCTR20230320011.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20230320011.